Cargando…
Uncover diagnostic immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation-related CCR5, CD86, CD8A, ITGAM, and PTPRC in kidney transplantation patients with allograft rejection
The aim of this study was to identify predictive immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation (EMT)-related biomarkers, pathways and new drugs in allograft rejection in kidney transplant patients. First, gene expression data were downloaded followed by identification of differe...
Autores principales: | He, Long, Wang, Boqian, Wang, Xueyi, Liu, Yuewen, Song, Xing, Zhang, Yijian, Li, Xin, Yang, Hongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639483/ https://www.ncbi.nlm.nih.gov/pubmed/36330810 http://dx.doi.org/10.1080/0886022X.2022.2141648 |
Ejemplares similares
-
Protein tyrosine phosphatase receptor type C (PTPRC or CD45)
por: Al Barashdi, Maryam Ahmed, et al.
Publicado: (2021) -
Clinical significance of CCR7(+)CD8(+) T cells in kidney transplant recipients with allograft rejection
por: Kim, Kyoung Woon, et al.
Publicado: (2018) -
CCR2 and PTPRC are regulators of tumor microenvironment and potential prognostic biomarkers of lung adenocarcinoma
por: Wei, Jie, et al.
Publicado: (2021) -
PTPRC (CD45) is not associated with multiple sclerosis in a large cohort of German patients
por: Miterski, Bianca, et al.
Publicado: (2002) -
C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease
por: Landskron, Johannes, et al.
Publicado: (2017)